PSMAddition: A phase III trial to compare treatment with (177)Lu-PSMA-617 plus standard of care (SOC) versus SOC alone in patients with metastatic hormone-sensitive prostate cancer Meeting Abstract
| Authors: | Tagawa, S. T.; Sartor, O.; Saad, F.; Sakharova, O.; de Bono, J.; Feng, F.; Fizazi, K.; Morris, M. J. |
| Abstract Title: | PSMAddition: A phase III trial to compare treatment with (177)Lu-PSMA-617 plus standard of care (SOC) versus SOC alone in patients with metastatic hormone-sensitive prostate cancer |
| Meeting Title: | ESMO Congress 2021 |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2021 Sep 16-21 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-09-01 |
| Start Page: | S673 |
| End Page: | S675 |
| Language: | English |
| ACCESSION: | WOS:000700527701113 |
| DOI: | 10.1016/j.annonc.2021.08.1160 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 647TiP -- Source: Wos |
